The merger frenzy in healthcare continues. In a deal that highlights tax inversion techniques, Pfizer and Allergen have announced a $160 billion merger. This deal creates the worlds largest drugmaker with high-profile products such as Botox, Lipitor and Viagra.
Read MoreA new report paid for by America’s Health Insurance Plans (AHIP) suggests a merger between Mountain States Health Alliance (MSHA) and Wellmont Health System would “likely lead to significantly higher post-merger prices.” AHIP aims to “advocate for public policies that expand access to affordable health care coverage to all Americans through a competitive marketplace that fosters choice, quality and innovation.” Competition Economics, LLC completed the report last month and concluded a merger would give the new organization a 77% market share, which would likely cause prices to shoot up.
Read MoreDue to low interest rates and cheap capital, merger activity has been exploding in nearly every industry. Healthcare is especially devoted to merger activity with the mantra that bigger is always better. U.S. Mergers and acquisitions announced in the first 9 months of 2015 are worth about $270 billion.
Read MorePerrigo, a global supplier of generic and over-the-counter drugs has been staving off a hostile takeover from Mylan for the last few months. Merger and acquisition activity in the healthcare sector is on a record pace even though Perrigo's Chief Executive Officer Joseph Papa has stated his disapproval of this deal.
Read MoreAccording to a Reuters report Pfizer and Allergan are in friendly but early talks to become the world's largest drugmaker. Allergan shares jumped 6.4 percent to $305.46 in U.S. trading, while Pfizer was off 2.7 percent at $34.51.
Read More
© 2013-2015 Copyright, MedicalGroups.com, Rational Actors Society Inc. All Rights Reserved
Medical Groups
Rational Actors Society Inc.
260 NEWPORT CENTER DRIVE STE. 210
NEWPORT BEACH, CA 92660
Site design by Experiencia Social
